Investor Connect 813: Ten Capital Event Part 4

In this episode of Investor Connect, we dive into two distinct yet promising sectors: medical diagnostics and sleep technology. Michael Cormack from Corwin Medical elaborates on the company's efforts to tackle peripheral artery disease (PAD) through innovative diagnostic systems that leverage multi-element ultrasound arrays and AI-based algorithms. He elaborates on the severe impact of PAD, its high mortality rate, and the cumbersome nature of current diagnostic tools like the Doppler Pencil Probe. Michael outlines their unique Ultrasense system, which promises faster, more accurate diagnostics, detailing a robust business model and strong leadership geared towards high-margin revenue and strategic industry partnerships with entities like Medtronic and Philips. He highlights the company's commercialization timeline and financial trajectory towards profitability by 2026, supported by a strong patent portfolio and seed funding efforts. The compelling patient stories and strong market need underscore the critical importance of their work in early PAD detection and intervention. Following this, we turn our focus to SleepScore Labs with Colin Lawlor, who shares his journey from ResMed to founding an organization dedicated to leveraging AI and data for improving consumer sleep. Recognizing sleep's critical role in overall health, Colin outlines how SleepScore Labs utilizes proprietary sleep data and intervention studies to provide companies with actionable insights and personalized coaching solutions. The importance of sleep for mitigating chronic diseases and optimizing wellness drives their market opportunity, particularly through B2B2C models with partners like Mattress Firm and Terabody. By highlighting their success in Germany, where their platform is reimbursed by insurance without a doctor's prescription, Colin emphasizes the robust, scalable business model ready to capitalize on the growing demand for sleep solutions. The episode closes with both Cormack and Lawlor discussing their exit strategies and potential for partnerships with industry giants, illustrating the potential for innovation in medical diagnostics and sleep technology. The detailed exploration into these fields gives investors and entrepreneurs critical insights into the paths to market success and the transformative potential of these cutting-edge technologies. Team and Funding 30:14 Q&A and Conclusion